IBL Tool - Digital Library

Digital Library

Journal description

All volumes of the corresponding journal

All issues of the corresponding volume

All articles of the corresponding issues

89 results found

no	title	author	magazine	year	volume	issue	page(s)	type
1	A fleeting glimpse of functional benefit of the complete DMD gene in a large animal model of Duchenne muscular dystrophy	Hoffman, Eric P.			33	C	p. 938-940	article
2	A neutralizable dimeric anti-thrombin aptamer with potent anticoagulant activity in mice	Nagano, Masanobu			33	C	p. 762-772	article
3	Angiotensin II mediates hypertensive cardiac fibrosis via an Erbb4-IR-dependent mechanism	Li, Jian-Chun			33	C	p. 180-190	article
4	An unbiased seed-based RNAi selection screen identifies small RNAs that inhibit androgen signaling and prostate cancer cell growth	Corbin, Joshua M.			33	C	p. 257-272	article
5	Apolipoprotein E and viral infection: Risks and Mechanisms	Chen, Feng			33	C	p. 529-542	article
6	Artificial intelligence enabled ChatGPT and large language models in drug target discovery, drug discovery, and development	Chakraborty, Chiranjib			33	C	p. 866-868	article
7	Asymmetric trichotomous partitioning overcomes dataset limitations in building machine learning models for predicting siRNA efficacy	Monopoli, Kathryn R.			33	C	p. 93-109	article
8	Branchpoints as potential targets of exon-skipping therapies for genetic disorders	Ohara, Hiroaki			33	C	p. 404-412	article
9	Bridging siRNA strands for better function	Rossi, John J.			33	C	p. 209	article
10	Can artificial intelligence-strengthened ChatGPT or other large language models transform nucleic acid research?	Chatterjee, Srijan			33	C	p. 205-207	article
11	Cancer kill code extension	Peter, Marcus E.			33	C	p. 773	article
12	Cathepsin B-activatable cyclic antisense oligonucleotides for cell-specific target gene knockdown in vitro and in vivo	Wang, Zhongyu			33	C	p. 548-558	article
13	Cell-type-specific alternative polyadenylation promotes oncogenic gene expression in non-small cell lung cancer progression	Huang, Kexin			33	C	p. 816-831	article
14	Characterization of cooperative PS-oligo activation of human TLR9	Pollak, Adam J.			33	C	p. 832-844	article
15	Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis	Pandey, Ekta			33	C	p. 430-443	article
16	Cis-Cardio: A comprehensive analysis platform for cardiovascular-relavant cis-regulation in human and mouse	Song, Chao			33	C	p. 655-667	article
17	Combining independent protein and cellular SELEX with bioinformatic analysis may allow high affinity aptamer hit discovery	Ducrot, Coline			33	C	p. 254-256	article
18	Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1	Osum, Sara H.			33	C	p. 227-239	article
19	Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy	Yi, Xianyanling			33	C	p. 376-390	article
20	Disease modeling and gene correction of LGMDR21 iPSCs elucidates the role of POGLUT1 in skeletal muscle maintenance, regeneration, and the satellite cell niche	Ortiz-Vitali, Jose L.			33	C	p. 683-697	article
21	DNM2 levels normalization improves muscle phenotypes of a novel mouse model for moderate centronuclear myopathy	de Carvalho Neves, Juliana			33	C	p. 321-334	article
22	Effects of Aptamer to U87-EGFRvIII Cells on the Proliferation, Radiosensitivity, and Radiotherapy of Glioblastoma Cells	Zhang, Xingmei			33	C	p. 428-429	article
23	Efficient circular RNA engineering by end-to-end self-targeting and splicing reaction using Tetrahymena group I intron ribozyme	Lee, Kyung Hyun			33	C	p. 587-598	article
24	Engineering B cells with customized therapeutic responses using a synthetic circuit	Page, Audrey			33	C	p. 1-14	article
25	Epigenetic therapy: BBC1115, a novel BET inhibitor with broad antitumor activity	Cingaram, Pradeep Reddy			33	C	p. 142-143	article
26	Estrogen-regulated miRs in bone enhance osteoblast differentiation and matrix mineralization	Emch, Michael J.			33	C	p. 28-41	article
27	EV-mediated promotion of myogenic differentiation is dependent on dose, collection medium, and isolation method	Hanson, Britt			33	C	p. 511-528	article
28	Expression of NORAD correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy	Alves-Vale, Catarina			33	C	p. 910-924	article
29	Fluorescent nanodiamonds as innovative delivery systems for MiR-34a replacement in breast cancer	Abate, Marianna			33	C	p. 127-141	article
30	Forging the future of circRNA therapeutics: Unleashing synthetic potential and conquering challenges	Qi, Dan			33	C	p. 42-43	article
31	Gymnotic uptake of AntimiRs alter microRNA-34a levels in 2D and 3D epithelial cell culture	Weidner, Julie			33	C	p. 898-907	article
32	Harnessing the potential of lipid nanoparticles for the delivery of chemically modified siRNA to combat hepatic adenovirus infection	Shubhra, Quazi T.H.			33	C	p. 44-46	article
33	Improved tropoelastin synthesis in the skin by codon optimization and nucleotide modification of tropoelastin-encoding synthetic mRNA	Golombek, Sonia			33	C	p. 642-654	article
34	Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers	Fitzsimons, Stephen			33	C	p. 941-959	article
35	Insight into the regulatory mechanism of dynamic chromatin 3D interactions during cardiomyocyte differentiation in human	Liu, Hui			33	C	p. 629-641	article
36	Integrated multiomics analysis and machine learning refine molecular subtypes and prognosis for muscle-invasive urothelial cancer	Chu, Guangdi			33	C	p. 110-126	article
37	Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists	Cirella, Assunta			33	C	p. 668-682	article
38	Intratumoral injection of IL-12-encoding mRNA targeted to CSF1R and PD-L1 exerts potent anti-tumor effects without substantial systemic exposure	Di Trani, Claudia Augusta			33	C	p. 599-616	article
39	Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C	De Cristofaro, Raimondo			33	C	p. 749	article
40	Lentiviral gene therapy reverts GPIX expression and phenotype in Bernard-Soulier syndrome type C	Martinez-Navajas, Gonzalo			33	C	p. 75-92	article
41	Leverage of nuclease-deficient CasX for preventing pathological angiogenesis	Han, Haote			33	C	p. 738-748	article
42	Lipid nanoparticle-targeted mRNA formulation as a treatment for ornithine-transcarbamylase deficiency model mice	Yamazaki, Kazuto			33	C	p. 210-226	article
43	Long-term muscle-specific overexpression of DOK7 in mice using AAV9-tMCK-DOK7	Huang, Yu-Ting			33	C	p. 617-628	article
44	MAVS is a double-edged sword	Huang, Christina			33	C	p. 869-870	article
45	Mesenchymal stem cell engineering by ARCA analog-capped mRNA	Andrzejewska, Anna			33	C	p. 454-468	article
46	MicroRNA-142a-3p regulates neurogenic skeletal muscle atrophy by targeting Mef2a	Gu, Xinyi			33	C	p. 191-204	article
47	Mini-PE, a prime editor with compact Cas9 and truncated reverse transcriptase	Lan, Ting			33	C	p. 890-897	article
48	Molnupiravir’s mechanism of action drives “error catastrophe” in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virus	Chatterjee, Srijan			33	C	p. 49-52	article
49	Nanoblades allow high-level genome editing in murine and human organoids	Tiroille, Victor			33	C	p. 57-74	article
50	Non-viral in vivo cytidine base editing in hepatocytes using focused ultrasound targeted microbubbles	Anderson, Cynthia D.			33	C	p. 733-737	article
51	Novel approaches to glaucomatous neurodegeneration, based on the integrated stress response	Chiarini, Luciana B.			33	C	p. 845-847	article
52	Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humans	Maurizi, Antonio			33	C	p. 925-937	article
53	Nucleic acid amphiphiles: Synthesis, properties, and applications	Gubu, Amu			33	C	p. 144-163	article
54	Overexpression of the mitochondrial anti-viral signaling protein, MAVS, in cancers is associated with cell survival and inflammation	Trishna, Sweta			33	C	p. 713-732	article
55	Peptide nanostructures-based delivery of DNA nanomaterial therapeutics for regulating gene expression	Baral, Bineeth			33	C	p. 493-510	article
56	Phenotypic features of dystrophin gene knockout pigs harboring a human artificial chromosome containing the entire dystrophin gene	Watanabe, Masahito			33	C	p. 444-453	article
57	PINE-TREE enables efficient enrichment of prime-edited hPSCs	Jia, Mary S.			33	C	p. 908-909	article
58	PINE-TREE enables highly efficient genetic modification of human cell lines	Frisch, Carlye			33	C	p. 483-492	article
59	Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G	Delviks-Frankenberry, Krista A.			33	C	p. 794-809	article
60	PPM1H is down-regulated by ATF6 and dephosphorylates p-RPS6KB1 to inhibit progression of hepatocellular carcinoma	Yang, Xiaoshuang			33	C	p. 164-179	article
61	Protospacer modification improves base editing of a canonical splice site variant and recovery of CFTR function in human airway epithelial cells	Joynt, Anya T.			33	C	p. 335-350	article
62	Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach	Centa, Jessica L.			33	C	p. 15-27	article
63	Putting a stop to nonsense: Revisiting gene correction therapy for neurofibromatosis type 1	Gutmann, David H.			33	C	p. 810-812	article
64	Quantum computing on nucleic acid research: Approaching towards next-generation computing	Chakraborty, Chiranjib			33	C	p. 53-56	article
65	Restoration of functional PAX6 in aniridia patient iPSC-derived ocular tissue models using repurposed nonsense suppression drugs	Lima Cunha, Dulce			33	C	p. 240-253	article
66	Retraction Notice to: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2	Hong, Sen			33	C	p. 208	article
67	RGC-specific ATF4 and/or CHOP deletion rescues glaucomatous neurodegeneration and visual function	Fang, Fang			33	C	p. 286-295	article
68	RNA nanoparticles for targeted therapies of triple-negative breast cancers	Danai, Leyla			33	C	p. 885-886	article
69	Role of long non-coding RNAs in cancer: From subcellular localization to nanoparticle-mediated targeted regulation	Wei, Chunfang			33	C	p. 774-793	article
70	Selection of a novel cell-internalizing RNA aptamer specific for CD22 antigen in B cell acute lymphoblastic leukemia	Ruiz-Ciancio, Dario			33	C	p. 698-712	article
71	SINEUPs to boost translation	Oliviero, Salvatore			33	C	p. 47-48	article
72	Targeting Duchenne muscular dystrophy by skipping DMD exon 45 with base editors	Gapinske, Michael			33	C	p. 572-586	article
73	Targeting microRNA-145-mediated progressive phenotypes of early bladder cancer in a molecularly defined in vivo model	Heishima, Kazuki			33	C	p. 960-982	article
74	Targeting oncogenic KRAS in non-small cell lung cancer with EGFR aptamer-conjugated multifunctional RNA nanoparticles	Yang, Linlin			33	C	p. 559-571	article
75	Targeting triple-negative breast cancer cells with a β1-integrin binding aptamer	Pleiko, Karlis			33	C	p. 871-884	article
76	The circular RNA Ataxia Telangiectasia Mutated regulates oxidative stress in smooth muscle cells in expanding abdominal aortic aneurysms	Fasolo, Francesca			33	C	p. 848-865	article
77	The current landscape of long COVID clinical trials: NIH’s RECOVER to Stanford Medicine’s STOP-PASC initiative	Chakraborty, Chiranjib			33	C	p. 887-889	article
78	The endosomal escape vehicle platform enhances delivery of oligonucleotides in preclinical models of neuromuscular disorders	Li, Xiang			33	C	p. 273-285	article
79	Therapeutic inhibition of miR-155 attenuates liver fibrosis via STAT3 signaling	Bala, Shashi			33	C	p. 413-427	article
80	Toward learning the rules that predict siRNA efficacy	Bofill-De Ros, Xavier			33	C	p. 543-544	article
81	Trans-acting aptazyme for conditional gene knockdown in eukaryotic cells	Zhou, Shan			33	C	p. 367-375	article
82	Treatment of autosomal dominant retinitis pigmentosa caused by RHO-P23H mutation with high-fidelity Cas13X in mice	Yan, Zixiang			33	C	p. 750-761	article
83	Treatment of CHO cells with Taxol and reversine improves micronucleation and microcell-mediated chromosome transfer efficiency	Uno, Narumi			33	C	p. 391-403	article
84	Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers	Liao, You-Cheng			33	C	p. 351-366	article
85	Two antisense RNAs—AFAP1-AS1 and MLK7-AS1—promote colorectal cancer progression by sponging miR-149-5p and miR-485-5p	Kim, Tae Won			33	C	p. 305-320	article
86	Unveiling ATF6 and PPM1H signaling in hepatocellular carcinoma progression: From ER stress to tumor suppression	Iyer, Prajish			33	C	p. 813-815	article
87	Unveiling the intricacies of gene delivery: Caveolae-mediated endocytosis induces efficient mRNA delivery in slow-dividing cells	den Roover, Sabine			33	C	p. 545-547	article
88	VWA3A-derived ependyma promoter drives increased therapeutic protein secretion into the CSF	Carrell, Ellie M.			33	C	p. 296-304	article
89	25 years of maturation: A systematic review of RNAi in the clinic	Corydon, Ida Juhl			33	C	p. 469-482	article

89 results found

Koninklijke Bibliotheek - National Library of the Netherlands